Home>News Center>World
         
 

Resistance to Tamiflu seen in Vietnam bird-flu case
By Marilyn Chase, Santanu Choudhury (The Wall Street Journal)
Updated: 2005-10-17 10:32

An Indian drug maker said it soon will produce a generic version of the antiviral considered to be the best treatment for bird flu, and scientists revealed worrying new details about a case in which the virus proved resistant to the drug.

Researchers said that the bird-flu virus found in a Vietnamese teenager in February was resistant to the drug Tamiflu. The girl later recovered, but the case, to be reported in the Oct. 20 issue of the journal Nature, heightens concern about the Roche Holding AG drug, currently the centerpiece of global and national drug stockpiles against a possible pandemic of H5N1 avian influenza.

The 14-year-old girl hadn't had direct contact with sick poultry but had cared for her 21-year-old brother while he was ill with a documented case of avian flu. Such circumstances "raise the possibility that the virus would have been transmitted from brother to sister," the researchers wrote. A handful of other cases have raised the same possibility, but sustained human-to-human transmission hasn't been proved.

Yoshihiro Kawaoka, a professor of virology at the University of Tokyo and senior author of the Nature study, said the discovery wasn't a surprise, given his earlier findings that 18% of Japanese children developed resistance after being treated with Tamiflu for normal, seasonal flu.

"The message is don't get panicked," said Dr. Kawaoka. "The vast majority of H5N1 viruses out there are still sensitive to oseltamivir," the generic name for Tamiflu, he said in an interview. "We should do what we planned, which is to stockpile oseltamavir, and perhaps we should consider zanamavir too," he added, referring to Relenza, the inhaled flu drug from Britain's GlaxoSmithKline PLC.

Amid calls for greatly increasing supplies of Tamiflu, meanwhile, Indian generic powerhouse Cipla Ltd. said Friday that it has synthesized the drug and could begin production in January or February.

The company said its generic oseltamivir won't be commercially launched, but only sold in countries that desperately need it -- not in Europe or North America.

Switzerland's Roche said in a written statement that it hasn't been approached by Cipla or any other company asking for the right to produce Tamiflu. Asked whether it would consider legal action against Cipla, Roche said, "We are not aware of any [patent] infringements and thus do not speculate on that."



USS Park Royal crew await for Rice
Coffin of Milosevic flew to Belgrade
Kidnapping spree in Gaza Strip
 
  Today's Top News     Top World News
 

Australia, US, Japan praise China for Asia engagement

 

   
 

Banker: China doing its best on flexible yuan

 

   
 

Hopes high for oil pipeline deal

 

   
 

Possibilities of bird flu outbreaks reduced

 

   
 

Milosevic buried after emotional farewell

 

   
 

China considers trade contracts in India

 

   
  Journalist's alleged killers held in Iraq
   
  No poisons found in Milosevic's body
   
  US, Britain, France upbeat on Iran agreement
   
  Fatah officials call for Abbas to resign
   
  Sectarian violence increases in Iraq
   
  US support for troops in Iraq hits new low
   
 
  Go to Another Section  
 
 
  Story Tools  
   
Manufacturers, Exporters, Wholesalers - Global trade starts here.
Advertisement
         
主站蜘蛛池模板: 亚洲国产高清视频在线观看| 国产男女猛烈无遮挡免费网站| 啊灬啊别停灬用力啊老师网站| free性欧美另类高清| 日本免费xxxx| 乱子轮熟睡1区| 欧美性xxxx极品hd欧美风情| 国产东北老头老太露脸 | av毛片免费看| 成人伊人青草久久综合网破解版| 亚洲国产美女精品久久| 粉色视频在线播放| 国产日韩精品一区二区三区在线| 91精品国产亚洲爽啪在线观看| 天天做日日做天天添天天欢公交车| 三男三女换着曰| 校花被折磨阴部流水| 亚洲精品国产成人| 男女国产一级毛片| 免费高清理伦片在线观看| 国产卡一卡二卡3卡4卡无卡视频| 好妈妈5韩国电影高清中字| 久久综合九色综合网站| 欧美多人野外伦交| 亚洲日韩精品欧美一区二区一| 美女脱一净二净不带胸罩| 国产人妖一区二区| 97久久超碰国产精品2021| 日本免费无遮挡吸乳视频电影| 亚洲AV乱码中文一区二区三区| 欧美人与物VIDEOS另类| 亚洲日产2021三区在线| 欧美精品久久天天躁| 午夜国产福利在线| 国产精品视频yuojizz| 国产精品免费无遮挡无码永久视频 | 成年网站在线播放| 久久久一本精品99久久精品88| 日本免费www| 久久久久国产精品免费看| 日本人六九视频jⅰzzz|